1. Home
  2. AURA vs CVGW Comparison

AURA vs CVGW Comparison

Compare AURA & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • CVGW
  • Stock Information
  • Founded
  • AURA 2007
  • CVGW 1924
  • Country
  • AURA United States
  • CVGW United States
  • Employees
  • AURA N/A
  • CVGW N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • CVGW Specialty Foods
  • Sector
  • AURA Health Care
  • CVGW Consumer Discretionary
  • Exchange
  • AURA Nasdaq
  • CVGW Nasdaq
  • Market Cap
  • AURA 438.3M
  • CVGW 517.5M
  • IPO Year
  • AURA 2021
  • CVGW N/A
  • Fundamental
  • Price
  • AURA $8.34
  • CVGW $25.13
  • Analyst Decision
  • AURA Strong Buy
  • CVGW Hold
  • Analyst Count
  • AURA 4
  • CVGW 1
  • Target Price
  • AURA $23.00
  • CVGW $32.00
  • AVG Volume (30 Days)
  • AURA 206.4K
  • CVGW 123.5K
  • Earning Date
  • AURA 11-12-2024
  • CVGW 01-14-2025
  • Dividend Yield
  • AURA N/A
  • CVGW 1.99%
  • EPS Growth
  • AURA N/A
  • CVGW N/A
  • EPS
  • AURA N/A
  • CVGW N/A
  • Revenue
  • AURA N/A
  • CVGW $1,011,635,000.00
  • Revenue This Year
  • AURA N/A
  • CVGW N/A
  • Revenue Next Year
  • AURA N/A
  • CVGW $3.27
  • P/E Ratio
  • AURA N/A
  • CVGW N/A
  • Revenue Growth
  • AURA N/A
  • CVGW 45.46
  • 52 Week Low
  • AURA $6.63
  • CVGW $20.30
  • 52 Week High
  • AURA $12.38
  • CVGW $31.26
  • Technical
  • Relative Strength Index (RSI)
  • AURA 39.95
  • CVGW 32.09
  • Support Level
  • AURA $8.30
  • CVGW $26.02
  • Resistance Level
  • AURA $9.04
  • CVGW $26.99
  • Average True Range (ATR)
  • AURA 0.46
  • CVGW 0.82
  • MACD
  • AURA 0.01
  • CVGW -0.13
  • Stochastic Oscillator
  • AURA 20.93
  • CVGW 1.72

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.

Share on Social Networks: